Nicholas Degner is the Medical Director of Clinical Development at BioNTech, where he is on a team developing a vaccine for tuberculosis. He is an infectious disease and public health physician with extensive experience in clinical, laboratory, and field settings across academia, industry, and government. He earned his MD from UC San Diego and an MPH from Johns Hopkins.
Outside of his direct professional roles, Nicholas has a significant background in academic research, having authored numerous publications on topics such as microbial cell-free DNA for diagnosing infections and the environmental potential of Mycobacterium tuberculosis. His work bridges cutting-edge clinical development with foundational scientific inquiry into infectious diseases.
He has conducted in-depth research into tuberculosis in international settings, including Brazil and South Africa, using mathematical modeling and microbial genetics.
Read the full overview →They prefer to do thorough analysis of any situation. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. They generally do not appreciate an overfriendly approach and prefer to stay to-the-point.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.